Is Cava’s Rapid Expansion a Risky Overstretch?
CAVA has been growing like a weed, now sporting 341 locations across 25 states. While the pace of new openings slowed slightly this year with just 33 new restaurants in the first 28 weeks of 2024 compared to 43 in 2023, the management still reported a solid 32.6% year-over-year revenue increase, and generated $487 million. » Read more about: Is Cava’s Rapid Expansion a Risky Overstretch? »
Read More
2 Cathie Wood Bargains (with HUGE Upside)
It’s no secret that Cathie Wood’s collection of ARK funds have had a horrendous 2022. Her ARKK flagship fund was down 53% year-to-date at the time of writing and traded in the mid-$30s as recently as June, down from a high of almost $100 per share at the start of the year.
But there’s light at the end of the tunnel for growth investors.
» Read more about: 2 Cathie Wood Bargains (with HUGE Upside) »
Read More
Cannabis Stock For Colossal Growth?
Competition is fierce in the cannabis industry. The Canadian market in particular has a litany of producers and sellers. The consequence of almost 1,000 licensed players elbowing each other for market share has been margin compression for most and losses for many.
As smaller producers creep into the market and steal market share inch by inch,
» Read more about: Cannabis Stock For Colossal Growth? »
Read More
The Next BIG Stock Split After Alphabet Is…
In theory nothing changes when a stock split occurs but in reality more buyers can afford to scoop up shares and so prices often rise when demand increases. As a result, stock splits are often viewed as bullish signs, even though theoretically nothing in the company’s fundamentals have changed.
Recently, Alphabet split its shares 20:1 from over $2,200 per share to closer to $110 per share.
» Read more about: The Next BIG Stock Split After Alphabet Is… »
Read MoreThe Ivy
Did Walmart Trainwreck The Whole Market?
Walmart (NYSE:WMT) tumbled in spite of strong Q4 results that revealed a 5.3% year-over-year sales increase to $182.6 billion and adjusted earnings per share up 10% to $0.66.
It’s confusing at first glance to figure out why the stock fell so sharply because both numbers beat analysts estimates.
» Read more about: Did Walmart Trainwreck The Whole Market? »
Read MoreThe Spotlight
Spotlight: Time To Buy Vaccine Manufacturer Before Winter?
It’s impossible to discuss Moderna without mentioning its COVID-19 vaccine, which propelled the stock to record highs in 2021 approaching $500 per share. However, slower sales caused the stock to plunge by almost 80%.
Second-quarter reports in 2023 show a net loss of $1.38 billion, a stark contrast to the net income of $5.4 billion in Q4 2021.
» Read more about: Spotlight: Time To Buy Vaccine Manufacturer Before Winter? »
Read MoreThe Daily
Legendary investor Ray Dalio says the stock market is headed for one last hurrah before the bubble bursts
Hedge fund icon Ray Dalio is sounding the alarm a lot this year over what he sees as the dire state of the US economy.
His main concern in recent months has been the impact of soaring US debt levels and high deficit spending; now, he’s raising red flags about the path of monetary policy.